DEC 23, 2021 3:00 AM PST

Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer

WRITTEN BY: Katie Kokolus

It is estimated that nearly 84,000 people will be diagnosed with bladder cancer in the United States this year, and almost 17,000 people will succumb to the disease. While bladder cancer occurs in both males and females, it is about three times more commonly diagnosed in males. One class of bladder cancer, non-muscle-invasive bladder cancer (NMIBC), develops in the tissue that lines the bladder without involving any muscle.  

Following a surgical intervention to remove the tumor, nearly 80% of NMIBC patients experience disease recurrence.  Because of the high recurrence rates, a significant amount of bladder cancer research focuses on extending long-lasting responses.

Medical guidelines call for that immediate delivery of chemotherapy following surgery, and a single instillation of chemotherapy significantly reduces recurrence rates for low- and medium-risk NMIBC patients.  However, physicians administer postoperative chemotherapy inconsistently, and it is unclear why there is so much divergence from the recommended guidelines.  

A study recently published in the Journal of Urology surveyed 58 urologists from the Michigan Urological Surgery Improvement Collaborative, a group focused on improving the value of urologic care. The goal of the study was to access clinical and environmental barriers that prevent urologists from offering immediate postoperative chemotherapy infusion to NIMBC patients.

The survey revealed that environmental factors presented the most significant barrier to administering postoperative chemotherapy.  Specifically, not have a standard operating procedure in place to distribute and dispose of chemotherapy in the surgical recovery room.  These findings dictate that non-clinical factors play a crucial role in doctors' treatment decisions.  The results present an urgent need to evaluate the setup of the operating and recovery rooms and refine the procedures put in place for doctors to order, administer, and dispose of chemotherapy quickly after surgery.

In summary, the study identifies specific aspects of patient care that hospitals could alter to accommodate more regular administration of chemotherapy to NIMBC patients following surgery.  This study could inform new standard operating procedures to ensure the immediate delivery of chemotherapy, a practice that could significantly reduce bladder cancer recurrence. 

 

Sources: CA, Br J Urology, Eur Urology, J Urology, J Urology

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JAN 06, 2022
Immunology
Gene for Smelling Helps Cancer Cells Move to the Brain
JAN 06, 2022
Gene for Smelling Helps Cancer Cells Move to the Brain
From tasting a delicious meal to picking up pheromones, olfaction (or the sense of smell) involves a network of complex ...
JAN 24, 2022
Microbiology
Potential Anti-Cancer Bacterium Found in Antarctic Sea Squirt
JAN 24, 2022
Potential Anti-Cancer Bacterium Found in Antarctic Sea Squirt
Some of our best medicine has come from nature, and scientists are always on the lookout for natural products that can b ...
FEB 11, 2022
Cancer
Aromatase Inhibitors versus Tamoxifen for the Treatment of Premenopausal Hormone Sensitive Breast Cancer
FEB 11, 2022
Aromatase Inhibitors versus Tamoxifen for the Treatment of Premenopausal Hormone Sensitive Breast Cancer
Breast cancer is the most prevalent cancer in women in the United States, and experts estimate that close to 3 ...
MAR 17, 2022
Cancer
John Joly and the "Dublin Method"
MAR 17, 2022
John Joly and the "Dublin Method"
St. Patrick’s Day is celebrated in Ireland and throughout the world in honor of the Irish saint who lived in the&n ...
APR 11, 2022
Genetics & Genomics
A New Way to Inhibit a Master Regulator
APR 11, 2022
A New Way to Inhibit a Master Regulator
Transcription factors are genes that, once expressed, can influence the activity of other genes, sometimes many other ge ...
APR 20, 2022
Cancer
"Saturating" the Liver with Chemotherapy to Treat Cancer
APR 20, 2022
"Saturating" the Liver with Chemotherapy to Treat Cancer
Uveal melanoma is a rare type of cancer that grows in the melanin, the dark-colored pigment of the eye. About  ...
Loading Comments...